What's Driving Biotech

Biotechnology, which has been on a roll, declined after the much anticipated American Society of Clinical Oncologists meeting in early June in New Orleans, where cancer specialists deliberated on the merits of new treatments. The two extant ETFs which focus on this industry are iShares Nasdaq Biotechnology (AMEX:IBB - News) and Biotech HOLDRs (AMEX:BBH - News). Before deciding to dump or load up on biotech ETFs, investors may find it worthwhile to look at the 3C's driving this sector: Cancer, Cycle-time, and Consolidation.